Abstract:Purpose: Monitoring tumor response during the course of treatment and adaptively modifying treatment plan based on tumor biological feedback may represent a new paradigm for radiotherapy. Diffusion MRI has shown great promises in assessing and predicting tumor response to radiotherapy. However, the conventional diffusion-weighted single-shot echo-planar-imaging (DW-ssEPI) technique suffers from limited resolution, severe distortion, and possibly inaccurate ADC at low field strength. The purpose of this work was to develop a reliable, accurate and distortion-free diffusion MRI technique that is practicable for longitudinal tumor response evaluation and adaptive radiotherapy on a 0.35 T MRI-guided radiotherapy system. Methods: A diffusion-prepared turbo spin echo readout (DP-TSE) sequence was developed and compared with the conventional diffusion-weighted single-shot echo-planar-imaging sequence on a 0.35 T MRI-guided radiotherapy system (ViewRay). A spatial integrity phantom was used to quantitate and compare the geometric accuracy of the two diffusion sequences for three orthogonal orientations. The apparent diffusion coefficient (ADC) accuracy was evaluated on a diffusion phantom under both 0 degrees C and room temperature to cover a diffusivity range between 0.40 x 10(-3) and 2.10 x 10(-3) mm(2)/s. Ten room temperature measurements repeated on five different days were conducted to assess the ADC reproducibility of DP-TSE. Two glioblastoma (GBM) and six sarcoma patients were included to examine the in vivo feasibility. The target registration error (TRE) was calculated to quantitate the geometric accuracy where structural CT or MR images were co-registered to the diffusion images as references. ADC maps from DP-TSE and DW-ssEPI were calculated and compared. A tube phantom was placed next to patients not treated on ViewRay, and ADCs of this reference tube were also compared. Results: The proposed DP-TSE passed the spatial integrity test (< 1 mm within 100 mm radius and < 2 mm within 175 mm radius) under the three orthogonal orientations. The detected errors were 0.474 0.355 mm, 0.475 +/- 0.287 mm, and 0.546 +/- 0.336 mm in the axial, coronal, and sagittal plane. DW-ssEPI, however, failed the tests due to severe distortion and low signal intensity. Noise correction must be performed for the DW-ssEPI to avoid ADC quantitation errors, whereas it is optional for DP-TSE. At 0 degrees C, the two sequences provided accurate quantitation with < 3% variation with the reference. In the room temperature study, discrepancies between ADCs from DP-TSE and the reference were within 4%, but could be as high as 8% for DW-ssEPI after the noise correction. Excellent ADC reproducibility with a coefficient of variation < 5% was observed among the 10 measurements of DP-TSE, indicating desirable robustness for ADC-based tumor response assessment. In vivo TRE in DP-TSE was less than 1.6 mm overall, whereas it could be greater than 12 mm in DW-ssEPI. For GBM patients, the CSF and brain tissue ADCs from DP-TSE were within the ranges found in literature. ADC differences between the two techniques were within 8% among the six sarcoma patients. For the reference tube that had a relatively low diffusivity, the two diffusion sequences provided matched measurements. Conclusion: A diffusion technique with excellent geometric fidelity, accurate, and reproducible ADC measurement was demonstrated for longitudinal tumor response assessment using a low-field MRI-guided radiotherapy system. (C) 2017 American Association of Physicists in Medicine

Rapid multicontrast brain imaging on a 0.35T MR‐linac

3D Isotropic Resolution Diffusion-Prepared Magnitude-Stabilized Bssfp Imaging with High Geometric Fidelity at 1.5 Tesla

Three-dimensional simultaneous brain T 1 , T 2 , and ADC mapping with MR Multitasking.

Cardiac Balanced Steady-State Free Precession MRI at 0.35 T: a Comparison Study with 1.5 T.

Three-dimensional Simultaneous Brain Mapping of T1, T2, T2*and Magnetic Susceptibility with MR Multitasking

Accuracy of UTE-MRI-based patient setup for brain cancer radiation therapy.

Distortion-Free Diffusion MRI using an MRI-Guided Tri-Cobalt 60 Radiotherapy System: Sequence Verification and Preliminary Clinical Experience.

STrategically Acquired Gradient Echo (STAGE) Imaging, Part III: Technical Advances and Clinical Applications of a Rapid Multi-Contrast Multi-Parametric Brain Imaging Method.

Technical feasibility of Magnetic Resonance Fingerprinting on a 1.5T MRI-Linac

Three-dimensional simultaneous brain T<sub>1</sub>, T<sub>2</sub>, and ADC mapping with MR Multitasking

Implementation of a dedicated 1.5 T MR scanner for radiotherapy treatment planning featuring a novel high-channel coil setup for brain imaging in treatment position

Optimization and validation of low-field MP2RAGE T1 mapping on 0.35T MR-Linac: Toward adaptive dose painting with hypoxia biomarkers

Implementation and evaluation of a dynamic contrast enhanced mr perfusion protocol for glioblastoma using a 0.35T mri-Linac system

Technical Development and In Silico Implementation of SyntheticMR in Head and Neck Adaptive Radiation Therapy: A Prospective R-IDEAL Stage 0/1 Technology Development Report

Quantitative MRI using STrategically Acquired Gradient Echo (STAGE): optimization for 1.5 T scanners and T1 relaxation map validation

Validation of daily 0.35 T diffusion‐weighted MRI for MRI‐guided glioblastoma radiotherapy

Rapid three-dimensional multiparametric MRI with quantitative transient-state imaging

TU-AB-BRA-09: A Novel Method of Generating Ultrafast Volumetric Cine MRI (VC-MRI) Using Prior 4D-MRI and On-Board Phase-Skipped Encoding Acquisition for Radiotherapy Target Localization.

Accurate, repeatable, and geometrically precise diffusion-weighted imaging on a 0.35 T Magnetic Resonance Imaging-guided linear accelerator

Phase-sensitive deep reconstruction method for rapid multiparametric MR fingerprinting and quantitative susceptibility mapping in the brain

Rapid high-resolution T1 mapping using a highly accelerated radial steady-state free-precession technique